Table 1: Clinical characteristics of patients treated with PCI in an acute phase of myocardial infarction with chronic ST segment elevation, depending on the blood glucose level on admission and the HbA1c level.

	Number (n)	Glc on admission 7.8 mmol/l	Present	p value	Number (n)	HbA1c 6.5%	Present	p value
Arterial hypertension	46	<	22 (47.8%)	0.296	71	<	36 (50.7%)	0.366
Arterial hypertension	46	≥	27 (58.7%)	0.296	21	≥	13 (61.9%)	0.366
Lipid metabolism disorders	46	<	28 (60.9%)	0.832	71	<	42 (59.2%)	0.821
Lipid metabolism disorders	46	≥	27 (58.7%)	0.832	21	≥	13 (61.9%)	0.821
BMI ≥30,0	46	<	8 (17.4%)	0.343	71	<	25 (35.2%)	0.019
BMI ≥30,0	46	≥	11 (23.1%)	0.343	21	≥	12 (57.1%)	0.019
Tobacco addiction	46	<	30 (65.2%)	0.204	71	<	45 (63.4%)	0.093
Tobacco addiction	46	≥	24 (52.2%)	0.204	21	≥	9 (42.9%)	0.093
CAD at family history	46	<	14 (30.4%)	0.482	71	<	20 (28.2%)	0.693
CAD at family history	46	≥	11 (23.9%)	0.482	21	≥	5 (23.8%)	0.693
Kidney diseases	46	<	2 (4.3%)	–	71	<	2 (2.8%)	–
Kidney diseases	46	≥	3 (6.5%)	–	21	≥	3(14.2%)	–
Thyroid diseases	46	<	4(8.7%)	–	71	<	6 (8.5%)	–
Thyroid diseases	46	≥	4 (8.7%)	–	21	≥	2 (9.5%)	–
A history of CAD	46	<	12 (26.1%)	0.203	71	<	14 (19.7%)	0.313
A history of CAD	46	≥	9 (19.6%)	0.203	21	≥	7 (33.3%)	0.313
State after myocardial infarction	46	<	2 (4.3%)	0.456	71	<	6 (8.5%)	0.330
State after myocardial infarction	46	≥	5 (10.9%)	0.456	21	≥	1 (4,8%)	0.330